-
Ticker
-
Advertisement
-
-
Dynamic view of the market
U.S. Markets close in 5 hrs, 55 mins
Symbol Value Change Percentage Change DJIA 10,233.44 6.50 0.06% NASDAQ 2,157.41 3.35 0.16% S&P 500 1,093.56 0.48 0.04%
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
-
Stock price
SGP is not a valid ticker symbol. Please correct your entry or search for the symbol using symbol lookup.
-
Real-Time Headlines
-
Monday, November 9, 2009
-
Big Pharma and Biotech - Industry Outlook
11/9/09 | Zacks Investment Research Saturday, November 7, 2009
-
Leerink's Major Pharmaceuticals Analyst hosts Analyst/Industry conference call
11/7/09 | Theflyonthewall.com Thursday, November 5, 2009
-
Merck & Co., Inc. CEO Plans to Keep Schering-Plough Corporation Headquarters
-
SADIF Analytics releases new summary due diligence report for Schering-Plough Corporation
11/5/09 | PR-inside - Austria Wednesday, November 4, 2009
-
Pulte Homes, Merck, Garmin are big movers
11/4/09 | AP ONLINE -
Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable
11/4/09 | Business Wire -
New Merck Begins Operations
11/4/09 | Business Wire Tuesday, November 3, 2009
-
11/03 - Schering-Plough reports Phase IIa study data for protease inhi ...
11/3/09 | Pharmacy Choice -
Edward Owens Top Stocks: ScheringPlough Corp., Forest Laboratories Inc., McKesson Corp. ...
11/3/09 | GuruFocus -
A Little Distracted, Are You, Merck?
11/3/09 | The Motley Fool -
Freeport McMoRan to be added to S&P 100 as of 11/5 close
11/3/09 | Theflyonthewall.com -
Priceline.com to be added to S&P 500 as of close tonight
11/3/09 | Theflyonthewall.com -
Merck and Schering-Plough to Complete Merger Today
-
Merck and Schering-Plough to complete merger today
11/3/09 | Theflyonthewall.com -
Merck and Schering-Plough to Complete Merger Today
11/3/09 | Business Wire -
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), An Investigational, Once-Daily Protease Inhibitor For Hepatitis C
-
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint In A Study Of Adult Subjects With A History Of Grass Pollen Allergies
11/3/09 | Medical News Today - UK Monday, November 2, 2009
-
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
-
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
11/2/09 | PR Newswire -
FDA Concerns Remain Over New Use for Schering-Plough Corporation Drug
-
GTx CEO Blames FDA for Bone Drug Rejection: BioBuzz
11/2/09 | TheStreet.com -
Dendreon Resubmits Provenge to FDA: BioBuzz
11/2/09 | TheStreet.com -
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
-
Schering investigational sublingual allergy tablet meets primary endpoint
11/2/09 | Theflyonthewall.com -
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
11/2/09 | PR Newswire -
Results from two Canadian studies confirm sustained viral response rates seen in hepatitis C patients treated with Pegatron
11/2/09 | PharmaLive -
Schering-Plough reports data on hepatitis C drug
-
Vertex Hep C Drug Emerges From Weekend Looking Stronger: BioBuzz
11/2/09 | TheStreet.com Sunday, November 1, 2009
-
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
-
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
11/1/09 | PR Newswire Saturday, October 31, 2009
-
Vertex Hep C Drug Cures 80% at New Dose: Study
10/31/09 | TheStreet.com Friday, October 30, 2009
-
FDA Issues Schering-Plough Complete Response Letter For Pegintron New Use - Update
-
2 Stocks Hitting High Notes
10/30/09 | The Motley Fool -
Schering-Plough receives complete response letter from FDA
10/30/09 | Theflyonthewall.com -
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
10/30/09 | PR Newswire -
Gold Weighed Down by Rising Dollar
10/30/09 | TheStreet.com -
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
-
Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco, and American Eagle Released by Seven Summits Research
10/30/09 | PR Newswire Thursday, October 29, 2009
-
WuXi AppTec Receives 2009 Schering-Plough Excellence Award
-
WuXi AppTec Receives 2009 Schering-Plough Excellence Award
10/29/09 | PR Newswire
1
<Next>
Monday, November 9, 2009
-
Big Pharma and Biotech - Industry Outlook
11/9/09 | Zacks Investment Research Saturday, November 7, 2009
-
Leerink's Major Pharmaceuticals Analyst hosts Analyst/Industry conference call
11/7/09 | Theflyonthewall.com Wednesday, November 4, 2009
-
Pulte Homes, Merck, Garmin are big movers
11/4/09 | AP ONLINE -
Fitch lowers Merck ratings after Schering purchase
Tuesday, November 3, 2009
-
Edward Owens Top Stocks: ScheringPlough Corp., Forest Laboratories Inc., McKesson Corp. ...
11/3/09 | GuruFocus -
A Little Distracted, Are You, Merck?
11/3/09 | The Motley Fool -
Freeport McMoRan to be added to S&P 100 as of 11/5 close
11/3/09 | Theflyonthewall.com -
Priceline.com to be added to S&P 500 as of close tonight
11/3/09 | Theflyonthewall.com -
Merck and Schering-Plough to complete merger today
11/3/09 | Theflyonthewall.com Monday, November 2, 2009
-
Schering-Plough reports results from Phase 2 study of Narlaprevir
11/2/09 | Theflyonthewall.com -
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
11/2/09 | StockHouse -
GTx CEO Blames FDA for Bone Drug Rejection: BioBuzz
11/2/09 | TheStreet.com -
Dendreon Resubmits Provenge to FDA: BioBuzz
11/2/09 | TheStreet.com -
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
-
Schering investigational sublingual allergy tablet meets primary endpoint
11/2/09 | Theflyonthewall.com -
Vertex Hep C Drug Emerges From Weekend Looking Stronger: BioBuzz
11/2/09 | TheStreet.com -
Schering-Plough reports data on hepatitis C drug
Sunday, November 1, 2009
-
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
11/1/09 | StockHouse Saturday, October 31, 2009
-
Vertex Hep C Drug Cures 80% at New Dose: Study
10/31/09 | TheStreet.com Friday, October 30, 2009
-
FDA Issues Schering-Plough Complete Response Letter For Pegintron New Use - Update
10/30/09 | RTTNews -
2 Stocks Hitting High Notes
10/30/09 | The Motley Fool -
Schering-Plough receives complete response letter from FDA
10/30/09 | Theflyonthewall.com -
Gold Weighed Down by Rising Dollar
10/30/09 | TheStreet.com -
Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators
Thursday, October 29, 2009
-
Freeport-McMoRan to move into S&P 100 index
-
Priceline.com to be added to S&P 500; Schering-Plough deleted on a date TBA
10/29/09 | Theflyonthewall.com -
Freeport McMoRan to be added to S&P 100; Schering-Plough deleted on a date TBA
10/29/09 | Theflyonthewall.com -
Merck and Schering-Plough receive FTC clearance
10/29/09 | Theflyonthewall.com -
Priceline.com Added To The S&P 500, Replacing Schering-Plough
10/29/09 | Benzinga -
SEC Filing: Quarterly Financials
10/29/09 | Thomson Financial -
Time Warner elects Schering-Plough CEO to board
-
Pharma Researchers Need a Cure
10/29/09 | The Motley Fool -
The GDP Mirage: Why the Data are Distorted
10/29/09 | BusinessWeek -
Procter & Gamble may eliminate some brands, acquire others, WSJ reports
10/29/09 | Theflyonthewall.com -
P&G Could Sell Some Brands, Buy Others
10/29/09 | TheStreet.com Wednesday, October 28, 2009
-
Vertex Hep C Drug Cures Hard-to-Treat Patients
10/28/09 | TheStreet.com Tuesday, October 27, 2009
-
Pfizer's and Merck's Loss Is These Companies' Gain
10/27/09 | The Motley Fool -
Vertex Posts Wider Loss - Analyst Blog
10/27/09 | Zacks Investment Research Monday, October 26, 2009
-
A Big Upgrade for Electro-Optical Sciences
10/26/09 | The Motley Fool -
Zacks Analyst Blog Highlights: Schering-Plough, Merck & Co., Sanofi-Aventis, Google and eBay - Press Releases
10/26/09 | Zacks Investment Research
1
<Next>
Thursday, November 5, 2009
-
Merck & Co., Inc. CEO Plans to Keep Schering-Plough Corporation Headquarters
-
SADIF Analytics releases new summary due diligence report for Schering-Plough Corporation
11/5/09 | PR-inside - Austria Tuesday, November 3, 2009
-
11/03 - Schering-Plough reports Phase IIa study data for protease inhi ...
11/3/09 | Pharmacy Choice -
Merck and Schering-Plough to Complete Merger Today
11/3/09 | StockWatch -
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), An Investigational, Once-Daily Protease Inhibitor For Hepatitis C
-
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint In A Study Of Adult Subjects With A History Of Grass Pollen Allergies
11/3/09 | Medical News Today - UK Monday, November 2, 2009
-
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
11/2/09 | StockWatch -
FDA Concerns Remain Over New Use for Schering-Plough Corporation Drug
-
Results from two Canadian studies confirm sustained viral response rates seen in hepatitis C patients treated with Pegatron
11/2/09 | PharmaLive -
Schering-Plough reports data on hepatitis C drug
Sunday, November 1, 2009
-
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Friday, October 30, 2009
-
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
Thursday, October 29, 2009
-
WuXi AppTec Receives 2009 Schering-Plough Excellence Award
10/29/09 | StockWatch -
FTC Clears Merger of Schering-Plough and Merck, but Requires Divestitures
-
Schering-Plough Chairman and CEO Fred Hassan Joins Time Warner’s Board of Directors
Monday, October 26, 2009
-
Merck & Co/Schering-Plough merger gets EU green light
Saturday, October 24, 2009
-
Schering-Plough 3rd Quarter Revenue Drops Steeply
10/24/09 | Drug Discovery & Development Thursday, October 22, 2009
-
Schering-Plough 3Q Earnings Down 16% On Charges
10/22/09 | NASDAQ -
Schering-Plough Reports Financial Results for 2009 Third Quarter
Friday, October 16, 2009
-
Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) And PEGINTRON(R) Data At The American Association For The Study Of Liver Diseases
Wednesday, October 14, 2009
-
OPKO Health Signs Agreement With Schering-Plough
10/14/09 | Pharmaceutical Business Review Online - UK -
Australian Regulator Oks Schering-Plough Acquisition Of Merck
10/14/09 | NASDAQ Tuesday, October 13, 2009
-
OPKO Health Acquires Lead NK-1 Compounds from Schering-Plough Corporation
-
SADIF Analytics releases new summary due diligence report for Schering-Plough Corporation
10/13/09 | PR-inside - Austria Monday, October 12, 2009
-
Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings
10/12/09 | StockWatch Friday, October 9, 2009
-
FDA Panel Backs Schering-Plough Cancer Drug
Thursday, October 8, 2009
-
Intervet/Schering-Plough Animal Health Announces Sponsorship Supporting Milk Producers In Malawi
10/8/09 | StockWatch Tuesday, October 6, 2009
-
UPDATE 1-J&J, Schering-Plough arthritis drug gets EU nod
Monday, October 5, 2009
-
Schering-Plough Canada announces $30.7 million expansion of Quebec plant in Pointe-Claire
-
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Thursday, October 1, 2009
-
FDA Finds "Subtantial" Toxicity with Schering-Plough Corporation's PegIntron Use
-
BRIEF-U.S. FDA staff: Schering-Plough's PegInterferon had "substantial" toxicity
10/1/09 | Interactive Investor - UK Monday, September 28, 2009
-
BioFocus DPI announces expanded drug discovery collaboration with Schering-Plough
9/28/09 | PR-inside - Austria Friday, September 25, 2009
-
BioFocus and Schering-Plough in 2.8 million drug discovery deal
9/25/09 | Script World Pharmaceutical News - UK Thursday, September 24, 2009
-
Galapagos announces expanded drug discovery collaboration with Schering-Plough
Friday, September 18, 2009
-
Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
9/18/09 | StockWatch Wednesday, September 16, 2009
-
Can Schering-Plough’s asenapine improve prospects for schizophrenia and bipolar patients
9/16/09 | PharmiWeb.com - UK Tuesday, September 15, 2009
-
Schering-Plough Corporation: PharmaVitae Profile - new market and company analysis
9/15/09 | PR-inside - Austria -
Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study In Treatment-Experienced HIV-Infected Patients
Monday, September 14, 2009
-
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Tuesday, November 3, 2009
-
Merck completes $41B purchase of Schering-Plough
Monday, November 2, 2009
-
Schering-Plough reports data on hepatitis C drug
Thursday, October 29, 2009
-
Merck's buy of Schering-Plough gets FTC approval
Saturday, October 24, 2009
-
EU approves Merck's takeover of Schering-Plough
Tuesday, October 13, 2009
-
Opko agrees to deal with Schering-Plough
10/13/09 | South Florida Business Journal - Deerfield Beach FL Monday, October 5, 2009
-
FDA panel backs Schering-Plough cancer drug
Thursday, October 1, 2009
-
U.S. regulators question benefits of Schering-Plough's PegIntron skin cancer drug
10/1/09 | Trenton Times - Trenton NJ Monday, September 21, 2009
-
Merck seeks EU approval to buy Schering-Plough
Wednesday, September 2, 2009
-
Schering-Plough loses $473 million tax dispute
Monday, August 31, 2009
-
Combined Merck-Schering-Plough plans fiv...
Wednesday, August 26, 2009
-
Schering-Plough Says EU Will Review Contraceptive
Friday, August 14, 2009
-
Schering-Plough gets FDA approval for Saphris
-
Schering-Plough gets FDA approval for Saphris
8/14/09 | The Kansas City Star - Kansas City MO Friday, August 7, 2009
-
Merck takeover of Schering-Plough up for vote
Wednesday, August 5, 2009
-
Merck, Schering-Plough in $42M Vytorin settlement
Tuesday, July 21, 2009
-
Schering-Plough 2nd-quarter profit jumps
Wednesday, July 15, 2009
-
Merck and Schering-Plough settle heart drug claims
Monday, June 22, 2009
-
FTC requests more info from Merck, Schering-Plough
Tuesday, June 16, 2009
-
Merck, Schering-Plough set meetings on merger
Monday, June 8, 2009
-
Alder expands antibody partnership with Schering-Plough
6/8/09 | Puget Sound Business Journal - Seattle WA Thursday, May 28, 2009
-
J&J files for arbitration over Schering deal
Thursday, May 21, 2009
-
Centocor exploring end to Remicade distribution deal with Schering-Plough
Thursday, April 30, 2009
-
Report: SEC probing some Schering-Plough trades
Tuesday, April 28, 2009
-
Schering-Plough CEO's pay falls 34 percent in 2008
Tuesday, April 21, 2009
-
Schering-Plough 1Q profit jumps
Thursday, April 9, 2009
-
Mylan settles patent dispute with Schering-Plough over Clarinex
4/9/09 | Pittsburgh Tribune-Review - Pittsburgh PA Monday, March 9, 2009
-
At A Glance: Merck and Schering-Plough
3/9/09 | Pittsburgh Tribune-Review - Pittsburgh PA -
At A Glance: Merck and Schering-Plough
3/9/09 | San Francisco Chronicle - San Francisco CA -
At A Glance: Merck and Schering-Plough
3/9/09 | The Kansas City Star - Kansas City MO -
At A Glance: Merck and Schering-Plough
3/9/09 | The San Diego Union Tribune - San Diego CA -
At A Glance: Merck and Schering-Plough
3/9/09 | The Patriot-News - Harrisburg PA -
Merck, Schering-Plough to merge in $41.1 B deal
Thursday, February 5, 2009
-
Schering-Plough ploughs £20m into Scottish arm